CNS Drugs
867 FDA-approved drugs
TheraRadar tracks 867 FDA-approved cns drugs from 306 companies across 49 drug classes, led by Teva, with 2,186 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for CNS.
CNS Approvals by Year
20
'15
14
'16
16
'17
22
'18
28
'19
15
'20
22
'21
23
'22
22
'23
23
'24
16
'25
1
'26
Recent CNS Drug Approvals
BYSANTI
MILSAPERIDONE
the: Treatment of schizophrenia in adults [see Clinical Studies (14...
2026-02-20
VANDA PHARMS INC
NEREUS
TRADIPITANT
the prevention of vomiting induced by motion in adults...
2025-12-30
VANDA PHARMS INC
DAYBUE STIX
TROFINETIDE
Rett syndrome in adults and pediatric patients 2 years of age and older...
2025-12-11
ACADIA PHARMS INC
DIROXIMEL FUMARATE
DIROXIMEL FUMARATE
relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remit...
2025-11-12
ZYDUS
SUBVENITE
LAMOTRIGINE
conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are re...
2025-09-16
OWP PHARMS
LEQEMBI IQLIK
LECANEMAB-IRMB
Alzheimer’s disease...
2025-08-29
EISAI INC
AMYLOID
ESCITALOPRAM
ESCITALOPRAM OXALATE
2025-08-29
ALPHAPHARM
TONMYA
CYCLOBENZAPRINE HYDROCHLORIDE
fibromyalgia in adults...
2025-08-15
TONIX
ARYNTA
LISDEXAMFETAMINE DIMESYLATE
( 1 ): Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and ...
2025-06-16
AZURITY
PERAMPANEL
PERAMPANEL
partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 ...
2025-05-23
TARO
BREKIYA (AUTOINJECTOR)
DIHYDROERGOTAMINE MESYLATE
the acute treatment of migraine headaches with or without aura and the acute treatment of cluster he...
2025-05-14
AMNEAL
ATZUMI
DIHYDROERGOTAMINE MESYLATE
the acute treatment of migraine with or without aura in adults...
2025-04-30
SATSUMA PHARMS
SIPONIMOD
SIPONIMOD
2025-04-22
RICONPHARMA LLC
MEZOFY
ARIPIPRAZOLE
2025-04-15
CMG PHARM CO LTD
BUCAPSOL
BUSPIRONE HYDROCHLORIDE
the management of anxiety disorders or the short-term relief of the symptoms of anxiety...
2025-03-13
EPIC PHARMA LLC
ONAPGO
APOMORPHINE HYDROCHLORIDE
motor fluctuations in adults with advanced Parkinson's disease...
2025-02-03
MDD US
SYMBRAVO
MELOXICAM
cluster headache...
2025-01-30
AXSOME
DEUTETRABENAZINE
DEUTETRABENAZINE
2024-12-26
Aurobindo Pharma
ONTRALFY
TIZANIDINE HYDROCHLORIDE
spasticity in adults...
2024-12-12
FIDELITY BIOPHARMA
RALDESY
TRAZODONE HYDROCHLORIDE
major depressive disorder (MDD) ( 1 )...
2024-11-26
KAMAT
Showing the 20 most recent of 867 cns drugs. View all 867 →
Top CNS Companies
CNS Active Trials by Indication
2,186 active trials — the forward pipeline, not just approvals.
Alzheimer's Disease 376 Major Depression 362 Parkinson's Disease 185 Multiple Sclerosis 184 Opioid Use Disorder 129 Schizophrenia 114 Alcohol Use Disorder 111 Anxiety 95
All competitive landscapes → CNS Drug Classes
Anti-epileptic Agent 25
Atypical Antipsychotic 23
Benzodiazepine 19
Osmotic Diuretic 16
Aromatic Amino Acid Decarboxylation Inhibitor 13
Central Nervous System Stimulant 9
Acetylcholine Release Inhibitor 7
Mood Stabilizer 7
Radioactive Diagnostic Agent 5
gamma-Aminobutyric Acid-ergic Agonist 4
CNS at a Glance
- Total Drugs
- 867
- Companies
- 306
- Drug Classes
- 49
- Active Trials
- 2,186
- Latest Approval
- 2026-02-20